Aria Pharmaceuticals, Inc.
Industry
- Pharmaceuticals
Other Names/Subsidiaries
- twoXAR Pharmaceuticals
Latest on Aria Pharmaceuticals, Inc.
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . BioDelivery Gains US Rights
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Zogenix Licenses Lead Candid
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Esperion Hooks Daiichi Sanky
Relay Therapeutics has raised $520m in venture capital since 2016, including a $400m Series C round announced on Dec. 20, without relaying a lot of information publicly about how it will translate it